Evidence map›Paper›PMID 36401795›Full record

ArticleThe FEBS journal2023

11-Cl-BBQ, a select modulator of AhR-regulated transcription, suppresses lung cancer cell growth via activation of p53 and p27

Bach D Nguyen, Brenna L Stevens, Daniel J Elson, Darren Finlay, John T Gamble, Prasad R Kopparapu, Robyn L Tanguay, Andrew B Buermeyer, Nancy I Kerkvliet, Siva K Kolluri

Open access · greenAbstract read
In one paragraph

Article in The FEBS journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Bach D NguyenCancer Research Laboratory, Department of Environmental & Molecular Toxicology, Oregon State University, Corvallis, OR, USA.
Brenna L StevensCancer Research Laboratory, Department of Environmental & Molecular Toxicology, Oregon State University, Corvallis, OR, USA.
Daniel J ElsonCancer Research Laboratory, Department of Environmental & Molecular Toxicology, Oregon State University, Corvallis, OR, USA.
Darren FinlayNCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
John T GambleCancer Research Laboratory, Department of Environmental & Molecular Toxicology, Oregon State University, Corvallis, OR, USA.
Prasad R KopparapuCancer Research Laboratory, Department of Environmental & Molecular Toxicology, Oregon State University, Corvallis, OR, USA.
Robyn L TanguayDepartment of Environmental & Molecular Toxicology, Oregon State University, Corvallis, OR, USA.
Andrew B BuermeyerDepartment of Environmental & Molecular Toxicology, Oregon State University, Corvallis, OR, USA.
Nancy I KerkvlietDepartment of Environmental & Molecular Toxicology, Oregon State University, Corvallis, OR, USA.
Siva K KolluriCancer Research Laboratory, Department of Environmental & Molecular Toxicology, Oregon State University, Corvallis, OR, USA.ORCID 0000-0003-1031-9827
Oregon State University · USSanford Burnham Prebys Medical Discovery Institute · US

Funding

Research Experience and Training Coordination CoreP42ES016465 · NIEHS · OREGON STATE UNIVERSITY · PI Robyn L Tanguay · 2009 to 2026
$52.5M
MODE OF ACTION OF ENVIRONMENTAL TOXICANTST32ES007060 · NIEHS · OREGON STATE UNIVERSITY · PI Jamie DeWitt, Siva Kumar Kolluri · 1985 to 2026
$11.6M
Zebrafish Biomedical Research Facility CoreP30ES030287 · NIEHS · OREGON STATE UNIVERSITY · PI Molly L Kile · 2020 to 2026
$9.8M
The AHR as a Novel Pathway to the Induction of Regulatory T cellsR01ES016651 · NIEHS · OREGON STATE UNIVERSITY · PI KERKVLIET, NANCY I · 2009 to 2017
$3.5M
NIEHS NIH HHS P30 ES030287NIEHS NIH HHS P42 ES016465NIEHS NIH HHS R01 ES016651NIEHS NIH HHS T32 ES007060NIEHS NIH HHS T32ES007060,5R01ES016651,P30ES030287
6 · The paper itself

Abstract

Aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor and functions as a tumour suppressor in different cancer models. In the present study, we report detailed characterization of 11-chloro-7H-benzimidazo[2,1-a]benzo[de]iso-quinolin-7-one (11-Cl-BBQ) as a select modulator of AhR-regulated transcription (SMAhRT) with anti-cancer actions. Treatment of lung cancer cells with 11-Cl-BBQ induced potent and sustained AhR-dependent anti-proliferative effects by promoting G1 phase cell cycle arrest. Investigation of 11-Cl-BBQ-induced transcription in H460 cells with or without the AhR expression by RNA-sequencing revealed activation of p53 signalling. In addition, 11-Cl-BBQ suppressed multiple pathways involved in DNA replication and increased expression of cyclin-dependent kinase inhibitors, including p27

Indexed as

Lung NeoplasmsReceptors, Aryl HydrocarbonBenzimidazolesCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p27HumansLungQuinolonesRNATumor Suppressor Protein p5311-Cl-BBQBenzimidazolesCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p27QuinolonesReceptors, Aryl HydrocarbonRNATumor Suppressor Protein p5311-Cl-BBQAhRG1 phase cell cycle arrestp27Kip1p53SA-β-gal

Identifiers

PMID36401795
PMCPMC10807707
OpenAlexW4309413185

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.